MiMedx Group Inc (MDXG)

5.77 -0.23 (-3.833%)

IEX Real-Time Price

September 25, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 6

Price Open 6.04

Volume: 2.49M

Avg Volume: 2.92M

Market Cap: 640.67M

P/E Ratio 48.08

52 Wk Range 3.005-18.25



MDXG Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-08-31
97.51M
58.98M
24.09
60.49%

2018-08-15
97.51M
57.28M
16.91
58.74%

2018-07-31
97.51M
56.69M
11.21
58.14%

2018-07-13
97.51M
50.13M
12.62
51.41%




MDXG Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-04-26
Q1 2018
BTO
0.09 (1)
0.00
0.00

2018-04-05
Q4 2017
N/A
0.11 (1)
0.00
0.00

2018-03-29
Q4 2017
N/A
0.00 (0)
0.00
0.00

2018-03-22
Q4 2017
N/A
0.00 (0)
0.00
0.00

News

MiMedx up 6% premarket on positive data on dHUC in diabetic foot ulcers (2018-09-25 08:46 SeekingAlpha)

MiMedx Group (NASDAQ: MDXG ) is up 6% premarket on light volume on the heels of the publication of a study evaluating its dehydrated human umbilical cord (dHUC) for the treatment of chronic diabetic foot ulcers in the International Wound Journal . More news on: MiMedx Group …

 

MiMedx Publishes Positive Results From Clinical Study Of Human Umbilical Cord For Diabetic Foot Ulcers (2018-09-25 08:30 PR Newswire)

MARIETTA, Ga. , Sept. 25, 2018 /PRNewswire/ --MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that a new clinical study has been published in the peer-reviewed International Wound Journal , which evaluat…

 


Statistics

Shares Outstanding: 111.03M

Top 15 Institution Percent: 61.60

Price To Sales: 8.31

Price To Book: 4.93

Revenue: 160.99M

Gross Profit: 142.76M

Cash: 84.06M

Debt: N/A

Return On Assets: 19.18

Return On Equity: 26.05

Profit Margin: 21.27

Price History

Beta: 1.78

50-day Moving Avg: 4.59

200-day Moving Avg: 8.16

YTD Change: -53.78

5-day Change: 13.64

1-month Change: 34.83

3-month Change: 2.92

6-month Change: -17.24

1-year Change: -51.42

Revenue Per Share: 1.00

Revenue Per Employee: 233312.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: MiMedx Group Inc

Exchange: NASDAQ Capital Market

Industry: Medical Devices

Sector: Healthcare

Website: http://www.mimedx.com

MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.